RAPACAN 1MG TABLET contains Sirolimus which belongs to the group of medicines called Immunosuppressants. It is used in adults to manage body from rejecting transplanted kidneys along with other immunosuppressant medicines called corticosteroids and initially (first 2-3 months) with ciclosporin.
RAPACAN 1MG TABLET is also used to manage sporadic lymphangioleiomyomatosis (S-LAM) with moderate lung disease or reducing lung function. Lymphangioleiomyomatosis (LAM) is a progressive lung disease in women caused by the abnormal growth of smooth muscle cells, most commonly characterized by shortness of breath.
Your doctor will perform tests to monitor RAPACAN 1MG TABLET levels in your blood, kidney function, blood fat levels and your liver function, during this management. They may also advise you to limit exposure to sunlight and UV light during RAPACAN 1MG TABLET management by covering your skin with clothing and using a sunscreen with a high protection factor as it can increase the risk for skin cancer.
Before taking RAPACAN 1MG TABLET inform your doctor if you have liver problem, body mass index more than 30 kg/m2 or if you previously had a failed kidney transplant. Do not drink grapefruit juice while taking RAPACAN 1MG TABLET. RAPACAN 1MG TABLET is not recommended for use in pregnant and breastfeeding women.
RAPACAN 1MG TABLET is not recommended for use in children and adolescents (below 18 years of age). The most common side effects of taking RAPACAN 1MG TABLET are pain, fever, headache, stomachache, swelling of body including hands and feet, etc. Contact your doctor if any of the symptoms worsen or persist.
No content available
